Thomas Mcgauley serves as Executive at GALECTIN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Thomas Mcgauley has executed 5 insider transactions totaling $81.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 30, 2026 involved exercising options for 50,000 shares valued at $0.
Thomas Mcgauley currently holds 50,000 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Mcgauley has been a net buyer of GALT stock. They have purchased $81.7K and sold $0 worth of shares.
Thomas Mcgauley's most recent insider trade was on Jan 30, 2026, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.34 |
| Discretionary |
| Nov 17, 2025 | TENX | $7.3K | Purchase | 1,000 | $7.35 | Discretionary |
| Nov 17, 2025 | TENX | $36.1K | Purchase | 5,000 | $7.23 | Discretionary |
| May 24, 2012 | GALT | $23.5K | Purchase | 10,000 | $2.35 | Discretionary |